SEPSIS 3 Critera for Risk Stratification in Emergency Patients
NCT ID: NCT02738164
Last Updated: 2016-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
879 participants
OBSERVATIONAL
2016-05-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Investigators will evaluate qSOFA performances and other SEPSIS 3 criterion in a population of emergency patients with infection
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Prognostic Performance of SEPSIS 2 and SEPSIS 3 Strategies at the Emergency Service
NCT03355833
Delta qSOFA for Risk Stratification in Emergency Infected Patients
NCT02926664
Evaluation of the Performance of Sepsis Predictive Scores on the Elderly Population in the Emergency Department.
NCT04721275
Implementation of a qSOFA Score in the Emergency Department
NCT04568746
Assessment of qSOFA in the Latin America Sepsis Institute Database
NCT03158493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of infection by the treating emergency physician
Exclusion Criteria
* pregnancy
* prisoner
* Low acuity infection (localised, not requiring general treatment, without any abnormal vital parameters)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Societe Française de Medecine d'urgence
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yonathan Freund, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
SFMU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Luc
Brussels, , Belgium
CHU Angers
Angers, , France
CHIPO
Beaumont S Oise, , France
Avicenne
Bobigny, , France
Saint Camille
Bry-sur-Marne, , France
Dijon
Dijon, , France
Grenoble
Grenoble, , France
Longjumeau
Longjumeau, , France
Lyon
Lyon, , France
Princess Grace
Monaco, , France
Nancy
Nancy, , France
Nice
Nice, , France
Ambroise Paré
Paris, , France
Bichat
Paris, , France
Cochin
Paris, , France
HEGP
Paris, , France
Lariboisière
Paris, , France
Pitie-salpetriere
Paris, , France
Saint-Antoine
Paris, , France
St Louis
Paris, , France
Tenon
Paris, , France
Strasbourg
Strasbourg, , France
Toulouse
Toulouse, , France
Tours
Tours, , France
Vienne
Vienne, , France
Clinic hospital Barcelona
Barcelona, , Spain
CHUV
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens YE, Avondo A, Occelli C, Feral-Pierssens AL, Truchot J, Ortega M, Carneiro B, Pernet J, Claret PG, Dami F, Bloom B, Riou B, Beaune S; French Society of Emergency Medicine Collaborators Group. Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department. JAMA. 2017 Jan 17;317(3):301-308. doi: 10.1001/jama.2016.20329.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCREEN_SFMU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.